Works matching AU Shore, Neal D.

Results: 109
    1
    2

    On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 275, doi. 10.1007/s40487-025-00334-6
    By:
    • Szabados, Bernadett E.;
    • Guerrero-Ramos, Félix;
    • Grande, Enrique;
    • Grivas, Petros;
    • Grünwald, Viktor;
    • Miguel, Marta Carpintero;
    • Hussain, Syed A.;
    • Kulkarni, Girish S.;
    • Wilson, Ana Lisa;
    • Shore, Neal D.;
    • Sridhar, Srikala S.;
    • Hoyt, Mary;
    • Strumeier, Samantha;
    • Sutton, Jennifer;
    • Brinkmann, Julia;
    • Teresi, Rosemary E.;
    • Todenhöfer, Tilman
    Publication type:
    Article
    3
    4
    5

    Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 5, p. e258751, doi. 10.1001/jamanetworkopen.2025.8751
    By:
    • Azad, Arun A.;
    • Petrylak, Daniel P.;
    • Iguchi, Taro;
    • Shore, Neal D.;
    • Villers, Arnauld;
    • Gomez-Veiga, Francisco;
    • Alcaraz, Antonio;
    • Alekseev, Boris;
    • Szmulewitz, Russell Z.;
    • Holzbeierlein, Jeffrey;
    • Rosbrook, Brad;
    • Ma, Jie;
    • Zohren, Fabian;
    • El-Chaar, Nader N.;
    • Haas, Gabriel P.;
    • Stenzl, Arnulf;
    • Armstrong, Andrew J.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 19, p. 1679, doi. 10.1001/jama.2025.3579
    By:
    • Kinnaird, Adam;
    • Luger, Ferdinand;
    • Cash, Hannes;
    • Ghai, Sangeet;
    • Urdaneta-Salegui, L. Felipe;
    • Pavlovich, Christian P.;
    • Brito, Joseph;
    • Shore, Neal D.;
    • Struck, Julian P.;
    • Schostak, Martin;
    • Harland, Niklas;
    • Rodriguez-Socarrás, Moisés;
    • Brisbane, Wayne G.;
    • Lughezzani, Giovanni;
    • Toledano, Harry;
    • Ouertani, Mohammed Salah;
    • Macek, Petr;
    • Fung, Christopher;
    • Tu, Wendy;
    • Gusenleitner, Andreas
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    Mechanism of action of nadofaragene firadenovec-vncg.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1359725
    By:
    • Narayan, Vikram M.;
    • Meeks, Joshua J.;
    • Jakobsen, Jørn S.;
    • Shore, Neal D.;
    • Sant, Grannum R.;
    • Konety, Badrinath R.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data.

    Published in:
    2020
    By:
    • Higano, Celestia S.;
    • Armstrong, Andrew J.;
    • Sartor, Oliver;
    • Vogelzang, Nicholas J.;
    • Kantoff, Philip W.;
    • McLeod, David G.;
    • Pieczonka, Christopher M.;
    • Penson, David F.;
    • Shore, Neal D.;
    • Vacirca, Jeffrey;
    • Concepcion, Raoul S.;
    • Tutrone, Ronald F.;
    • Nordquist, Luke T.;
    • Quinn, David I.;
    • Kassabian, Vahan;
    • Scholz, Mark C.;
    • Harmon, Matt;
    • Tyler, Robert C.;
    • Chang, Nancy N.;
    • Tang, Hong
    Publication type:
    Letter
    41

    Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.

    Published in:
    2019
    By:
    • Higano, Celestia S.;
    • Armstrong, Andrew J.;
    • Sartor, A. Oliver;
    • Vogelzang, Nicholas J.;
    • Kantoff, Philip W.;
    • McLeod, David G.;
    • Pieczonka, Christopher M.;
    • Penson, David F.;
    • Shore, Neal D.;
    • Vacirca, Jeffrey;
    • Concepcion, Raoul S.;
    • Tutrone, Ronald F.;
    • Nordquist, Luke T.;
    • Quinn, David I.;
    • Kassabian, Vahan;
    • Scholz, Mark C.;
    • Harmon, Matt;
    • Tyler, Robert C.;
    • Chang, Nancy N.;
    • Tang, Hong
    Publication type:
    journal article
    42

    Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.

    Published in:
    Oncologist, 2024, v. 29, n. 7, p. 581, doi. 10.1093/oncolo/oyae019
    By:
    • Shore, Neal D;
    • Gratzke, Christian;
    • Feyerabend, Susan;
    • Werbrouck, Patrick;
    • Carles, Joan;
    • Vjaters, Egils;
    • Tammela, Teuvo L J;
    • Morris, David;
    • Aragon-Ching, Jeanny B;
    • Concepcion, Raoul S;
    • Emmenegger, Urban;
    • Fleshner, Neil;
    • Grabbert, Markus;
    • Lietuvietis, Vilnis;
    • Mahammedi, Hakim;
    • Cruz, Felipe M;
    • Paula, Adriano;
    • Pieczonka, Christopher;
    • Rannikko, Antti;
    • Richardet, Martin
    Publication type:
    Article
    43
    44

    Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.

    Published in:
    Oncologist, 2018, v. 23, n. 2, p. 193, doi. 10.1634/theoncologist.2017-0413
    By:
    • Sartor, Oliver;
    • Vogelzang, Nicholas J.;
    • Sweeney, Christopher;
    • Fernandez, Daniel C.;
    • Almeida, Fabio;
    • Iagaru, Andrei;
    • Brown Jr., Alan;
    • Smith, Matthew R.;
    • Agrawal, Manish;
    • Dicker, Adam P.;
    • Garcia, Jorge A.;
    • Lutzky, Jose;
    • Wong, Yu‐Ning;
    • Petrenciuc, Oana;
    • Gratt, Jeremy;
    • Shore, Neal D.;
    • Morris, Michael J.;
    • for the U.S. Expanded Access Program Investigators
    Publication type:
    Article
    45
    46
    47
    48
    49
    50